Table 3 Predictors of 28 day survival among patients with Acinetobacter baumannii infections.
Clinical Characteristic | 28 Day Survival | Univariate P-value | OR (95%CI) | Multivariate P-value | OR (95%CI) | |
|---|---|---|---|---|---|---|
Alive (n = 33) | Dead (n = 17) | |||||
Age | 40.9 (11.6) | 43.6 (17.5) | 0.51 | 0.99 (0.94–1.03) | — | — |
Male | 29 (87.9%) | 17 (100%) | 0.18 | 0.63 (0.51–0.79) | — | — |
Length of stay | 41.3 (22.1) | 29.9 (29.9) | 0.14 | 1.02 (0.99–1.05) | — | — |
Mechanical ventilation | 11 (33.3%) | 13 (76.5%) | 0.004 | 6.50 (1.71–24.68) | 0.59 | 1.62 (0.27–9.64) |
Resistance pattern | 0.98 | 0.99 (0.56–1.77) | — | — | ||
MDR | 5 (15.2%) | 2 (11.8%) | ||||
XDR | 8 (24.2%) | 4 (23.5%) | ||||
PXR | 10 (30.3%) | 7 (41.2%) | ||||
NDR | 10 (30.3%) | 4 (23.5%) | ||||
CD4+ T lymphocyte count | 19.0 (6.0–54.5) | 8.0 (4.5–62.0) | 0.57 | 0.99 (0.98–1.01) | — | — |
CD4/ CD8 ratio | 0.08 (0.02–0.13) | 0.05 (0.02–0.11) | 0.68 | 5.14 (0.02–12.10) | — | — |
APACHE II score | 16.0 (12.0–21.5) | 22.0 (19.0–26.0) | 0.002 | 1.26 (1.09–1.45) | 0.031 | 1.22 (1.02–1.45) |
ART | 7 (21.2%) | 3 (17.6%) | 0.77 | 0.80 (0.18–4.57) | — | — |
Tigecycline | 11 (33.3%) | 4 (23.5%) | 0.48 | 0.62 (0.16–2.34) | — | — |
